Showing 38,301 - 38,320 results of 70,031 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.84s Refine Results
  1. 38301

    Table_7_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  2. 38302

    Table_5_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  3. 38303
  4. 38304
  5. 38305
  6. 38306

    Image_1_U-shaped GAN for Semi-Supervised Learning and Unsupervised Domain Adaptation in High Resolution Chest Radiograph Segmentation.PDF by Hongyu Wang (366946)

    Published 2022
    “…Moreover, we design the U-shaped net with a pretrained ResNet-50 as an encoder to reduce the computational burden of training the encoder from scratch. …”
  7. 38307
  8. 38308
  9. 38309
  10. 38310
  11. 38311
  12. 38312

    Table_2_Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis.DOC by Ke Du (511486)

    Published 2022
    “…There was statistically non-significant for Mg level in CSF between AD and HCs, whereas a decreased tendency were detected (SMD = −0.16; 95% CI [−0.50, 0.18]; P = 0.364). .In addition, when we analyzed the Mg levels of serum, plasma and CSF together, the circulating Mg levels in AD patients was significantly lower (SMD = −0.74, 95% CI [−1.13; −0.35]; P = 0.000). …”
  13. 38313
  14. 38314
  15. 38315
  16. 38316

    Table_4_Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease.docx by Eliana Shaul (13827001)

    Published 2022
    “…Number of hospitalizations (p<0.01) and length of stay (p<0.05) decreased. Growth improved with median weight-for-length Z-score increasing from -1.01 to 1.1 in children less than 2 years old. …”
  17. 38317

    Table_2_Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease.xlsx by Eliana Shaul (13827001)

    Published 2022
    “…Number of hospitalizations (p<0.01) and length of stay (p<0.05) decreased. Growth improved with median weight-for-length Z-score increasing from -1.01 to 1.1 in children less than 2 years old. …”
  18. 38318

    Table_3_Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease.xlsx by Eliana Shaul (13827001)

    Published 2022
    “…Number of hospitalizations (p<0.01) and length of stay (p<0.05) decreased. Growth improved with median weight-for-length Z-score increasing from -1.01 to 1.1 in children less than 2 years old. …”
  19. 38319
  20. 38320

    Supplementary Material for: Body mass index and all-cause mortality in elderly patients with percutaneous coronary intervention: A meta-analysis by Wang Y. (2884271)

    Published 2024
    “…Relative to normal weight group, overweight and obesity groups had decreased all-cause mortality (RR 0.86, 95%CI 0.77-0.95 for overweight group; RR 0.57,95%CI 0.40-0.80 for obesity group), while underweight group had elevated all-cause mortality (RR 1.52, 95%CI 1.01-2.29). …”